Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial (BMIC-006)

The PACIFIC Trial in Stage 3 NSCLCПодробнее

Immunotherapy in Stage III NSCLCПодробнее

Reactions to the PACIFIC Trial in Stage III NSCLCПодробнее

Immunotherapy for Management of Stage 3B NSCLCПодробнее

Updated Results on PACIFIC Trial: Revise Who Should Receive Consolidation Immunotherapy? (BMIC-065)Подробнее

Results from the PACIFIC study: durvalumab with chemoradiation for the treatment of NSCLCПодробнее

PACIFIC Trial: Durvalumab for Stage 3 NSCLCПодробнее

Dr. Langer on Practice-Changing PACIFIC Data in Stage III NSCLCПодробнее

Immunotherapy in Stage III NSCLCПодробнее

PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLCПодробнее

Lung Cancer Video Library - Immunotherapy in Stage lll NSCLC - The Pacific Trial and ImfinziПодробнее

Durvalumab Consolidation in NSCLC: The PACIFIC TrialПодробнее

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care? (BMIC-024)Подробнее

PACIFIC trial of durvalumab for stage III NSCLCПодробнее

Dr. Schwartz on the Results of the PACIFIC TrialПодробнее

Dr. Langer on the Impact of the PACIFIC Trial on Stage III NSCLCПодробнее

Reactions to the PACIFIC Trial in Stage III NSCLCПодробнее

Phase III real-world PACIFIC-R trial for NSCLCПодробнее

PACIFIC Trial in LA NSCLCПодробнее